References
- Steinberg M H, Forget B G, Higgs D R, Nagel R L. Genetics of the βS gene: origins, genetic epidemiology, and epistasis in sickle cell anemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, M H Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press, New York 2001; 711–755
- Koren A, Zalman L, Levin C, Abu H M, Mader R, Shalev S. Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient. Pediatr Hematol Oncol 1999; 16(5)469–472
- Nizankowska‐Mogilnicka E, Adamek L, Grzanka P, Domagala T B, Sanak M, Krzanowski M, Szczeklik A. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J 2003; 21(1)25–30
- Nestoridi E, Buonanno F S, Jones R M, Krishnamoorthy K, Grant P E, van Cott E M, Grabowski E F. Arterial ischemic stroke in childhood: the role of plasma‐phase risk factors. Curr Opin Neurol 2002; 15(2)139–144
- Krieger H, Morton N E, Mi M P, Azêvedo E, Freire‐Maia A, Yasuda N. Racial admixture in North‐Eastern Brazil. Ann Hum Genet 1965; 29(2)113–125
- Azêvedo E, Alves A F, Da Silva M C, Souza M G, Muniz Dias Lima A M, Azevedo W C. Distribution of Abnormal hemoglobins and glucose‐6‐phosphate dehydrogenase variants in 1200 school children of Bahia, Brazil. Am J Phys Anthropol 1980; 53(4)509–512
- Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88(10)3698–3703
- Frosst P, Blom H J, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10(1)111–113
- Adams G T, Snieder H, McKie V C, Clair B, Brambilla D, Adams R J, Kutlar F, Kutlar A. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case‐control association study and genomewide screen. BMC Med Genet 2003; 4(1)6–15
- Fletcher O, Kessling A M. MTHFR association with arteriosclerotic vascular disease. Hum Genet 1998; 103(1)11–21
- Couto F D, Adorno E V, Menezes J F, Moura Neto J P, Rego M A, dos Reis M G, Goncalves M S. C677T polymorphism of the MTHR gene and variant hemoglobins: a study in newborns from Salvador, Bahia, Brazil. Cad Saude Publica 2004; 20(2)529–533, In press
- Franco R F, Araújo A G, Guerreiro J F, Elion J, Zago M A. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998; 79(1)119–121
- Arruda V R, Siqueira L H, Gonçalves M S, von Zuben P M, Soares M C, Menezes R, Annichino‐Bizzacchi J M, Costa F F. Prevalence of the mutation C677T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 1998; 78(4)332–335
- Rosendaal F R, Doggen C J, Zivelin A, Arruda V R, Aiach M, Siscovick D S, Hillarp A, Watzke H H, Bernardi F, Cumming A M, Preston F E, Reitsma P H. Geographic distribution of the 20210 G→A prothrombin variant. Thromb Haemost 1998; 79(4)706–708
- Dilley A, Austin H, Hooper W C, El‐Jamil M, Whitsett C, Wenger N K, Benson J, Evatt B. Prevalence of the prothrombin 20210 G→A variant in Blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 1998; 132(6)452–455
- Dean A G, Dean J A, Epi Info C D. Version 6: A Word Processing Program for Public Health on IBM‐compatible Microcomputers. Center for Disease Control and Prevention, Atlanta. 1994